In statin-sensitive lung cancer cells, atorvastatin reduces intracellular cholesterol esters and downregulates SOAT1 expression, whereas resistant cells maintain both, suggesting that effective statin action requires SOAT1 suppression [76]. The gene discussed is SOAT1; the disease is lung carcinoma.